Despite high proportions of T cells and non-lymphocyte populations identified as positive for CCR6 and CCL20 via scRNA-seq respectively, CCR6+ T cells were not enriched in glioblastoma and we were unable to detect CCL20 in supernatants via ELISA. This evidence concerns the gene CCL20 and glioblastoma.